Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart

BACKGROUND: More than 90% of Duchenne muscular dystrophy (DMD) patients develop cardiomyopathy, and many die of cardiac failure. Despite tremendous progress in skeletal muscle gene therapy, few attempts have been made to treat cardiomyopathy. Microdystrophin genes are shown to correct skeletal muscl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yue, Yongping, Li, Zhenbo, Harper, Scott Q., Davisson, Robin L., Chamberlain, Jeffrey S., Duan, Dongsheng
Médium: Artigo
Jazyk:Inglês
Vydáno: 2003
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581719/
https://ncbi.nlm.nih.gov/pubmed/12952841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/01.CIR.0000089371.11664.27
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky